STE Past Earnings image   This STE past earnings page last updated 11/11/2022
STE Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 202311/9/20221.990
Q1 20238/2/20221.900
Q4 20225/11/20222.040
Q3 20222/8/20222.120
Q2 202211/2/20211.990
Q1 20228/9/20211.760
Q4 20215/18/20211.630
Q3 20212/2/20211.730
Q2 202111/2/20201.480
Q1 20218/3/20201.310
Q4 20205/13/20201.640
Q3 20202/10/20201.450
Q2 202011/4/20191.320
Q1 20208/5/20191.230
Q4 20195/13/20191.530
Q3 20192/11/20191.26
Q2 201911/6/20181.1
Q1 20198/8/20181
Q4 20185/9/20181.24
Q3 20182/7/20181.12
Q2 201811/1/20170.94
Q1 20188/8/20170.85
Q4 20175/9/20171.11
Q3 20172/7/20170.98
Q2 201711/2/20160.89
Q1 20178/9/20160.79
Q4 20165/18/20160.9
Q3 20162/9/20160.98
Q2 201610/30/20150.83
Q1 20168/4/20150.62
Q4 20155/7/20150.98
Q3 20152/4/20150.79
Q2 201511/4/20140.68
Q1 20158/5/20140.54
Q4 20145/8/20140.91
Q3 20142/5/20140.59
Q2 201410/30/20130.55
Q1 20148/7/20130.44
Q4 20135/7/20130.7
Q3 20132/6/20130.58
Q2 201310/31/20120.53
Q1 20138/2/20120.52
STE Past Revenue
PeriodPast Earnings DateGAAP
Q2 202311/9/20221.20B
Q1 20238/2/20221.16B
Q4 20225/11/20221.21B
Q3 20222/8/20221.21B
Q2 202211/2/20211.20B
Q1 20228/9/20210.97B
Q4 20215/18/20210.87B
Q3 20212/2/20210.81B
Q2 202111/2/20200.76B
Q1 20218/3/20200.67B
Q4 20205/13/20200.82B
Q3 20202/10/2020774.26M
Q2 202011/4/20190.74B
Q1 20208/5/20190.70B
Q4 20195/13/20190.77B
Q3 20192/11/2019696.24M
Q2 201911/6/2018678.96M
Q1 20198/8/2018638.76M
Q4 20185/9/2018715.97M
Q3 20182/7/2018661.90M
Q2 201811/1/2017634.16M
Q1 20188/8/2017607.96M
Q4 20175/9/2017681.19M
Q3 20172/7/2017646.77M
Q2 201711/2/2016646.41M
Q1 20178/9/2016638.38M
Q4 20165/18/2016690.28M
Q3 20162/9/2016618.69M
Q2 201610/30/2015489.90M
Q1 20168/4/2015439.90M
Q4 20155/7/2015501.65M
Q3 20152/4/2015473.20M
Q2 201511/4/2014462.70M
Q1 20158/5/2014412.60M
Q4 20145/8/2014465.30M
Q3 20142/5/2014405.60M
Q2 201410/30/2013383.80M
Q1 20148/7/2013367.70M
Q4 20135/7/2013428.20M
Q3 20132/6/2013380.40M
Q2 201310/31/2012356.30M
Q1 20138/2/2012337.00M
Quotes delayed 20 minutes

Email EnvelopeFree STE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Steris (STE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

STIM Past Earnings
STOK Past Earnings
STRO Past Earnings
STRR Past Earnings
STSA Past Earnings
STTK Past Earnings
SUPN Past Earnings
SURF Past Earnings
SVRA Past Earnings
SWAV Past Earnings

STE Past Earnings Q&A

What was the best and worst STE past earnings results?
For Steris, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest STE past earnings result in our data set was 2.120/share posted in Q3 2022, while the lowest was in Q1 2014 when STE posted 0.44/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2022 when STE reported 1.21B in revenue, while the quarter with the lowest revenue in our data set was Q1 2013 at 337.00M of revenue.

  Suggested answer: There are 42 STE past earnings results in our data set.

On this page we presented the STE past earnings date information for Steris. Reviewing that STE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when STE posted adjusted EPS of 2.120/share. Meanwhile the lowest STE past earnings result was in Q1 2014, when STE posted adjusted EPS of 0.44/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2022 when STE reported 1.21B in revenue, while the smallest revenue quarter was Q1 2013 when STE reported 337.00M in revenue.

Any self directed investor doing their due diligence on STE or any other given stock can benefit from researching all of the Steris past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Steris past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for STE. Thanks for visiting, and the next time you need to research STE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of LLSC, PSMT Videos, Funds Holding SPMD.

 

STE Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.